Stocks Explorer
Stocks
Sectors
Search
BIOPORTO A/S B DK 1(2P4) News
Profile
Chart
News
Analysis
2P4 price today
by TradingView
Date
Title
Jun 27
Initiation of commercialization of ProNephro AKI (NGAL) for diagnostic use in the US
Jan 23
BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals
‹ Prev
Page
of 1
Next ›